Clorazepate

Clorazepate
Clinical data
Trade namesTranxene, Tranxilium, Novo-Clopate
Other namesClorazepate dipotassium
AHFS/Drugs.comMonograph
MedlinePlusa682052
Routes of
administration
Oral
ATC code
Legal status
Legal status
Pharmacokinetic data
Bioavailability91%
MetabolismHepatic
Elimination half-life48 hours
ExcretionRenal
Identifiers
  • (RS)-7-Chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.041.737
Chemical and physical data
FormulaC16H11ClN2O3
Molar mass314.73 g·mol−1
3D model (JSmol)
  • O=C(O)C1N=C(c2ccccc2)c2cc(Cl)ccc2NC1=O
  • InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22) Y
  • Key:XDDJGVMJFWAHJX-UHFFFAOYSA-N N
 NY (what is this?)  (verify)

Clorazepate, sold under the brand name Tranxene among others, is a benzodiazepine medication. It possesses anxiolytic, anticonvulsant, sedative, hypnotic, and skeletal muscle relaxant properties. Clorazepate is an unusually long-lasting benzodiazepine and serves as a prodrug for the equally long-lasting desmethyldiazepam, which is rapidly produced as an active metabolite. Desmethyldiazepam is responsible for most of the therapeutic effects of clorazepate.

It was patented in 1965 and approved for medical use in 1967.